Orchestra BioMed (OBIO) Insider Trading & Ownership $2.85 -0.01 (-0.35%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.24 +0.40 (+13.86%) As of 04/17/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Orchestra BioMed (NASDAQ:OBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$109,845.00Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$138,572.97 Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OBIO Insider Buying and Selling by Quarter Orchestra BioMed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2024David P HochmanInsiderBuy4,000$4.66$18,640.00 12/19/2024Andrew Lawrence TaylorCFOBuy1,000$4.83$4,830.00 12/18/2024David P HochmanInsiderBuy5,000$4.91$24,550.00 9/24/2024David P HochmanInsiderBuy2,500$4.91$12,275.00 9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92 9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.00 9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35 9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.00 9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70 8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00 5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00 (Data available from 1/1/2013 forward) OBIO Insider Trading Activity - Frequently Asked Questions Who is on Orchestra BioMed's Insider Roster? The list of insiders at Orchestra BioMed includes Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Eric S Fain, and William Reed Little. Learn more on insiders at OBIO. What percentage of Orchestra BioMed stock is owned by insiders? 6.70% of Orchestra BioMed stock is owned by insiders. Learn more on OBIO's insider holdings. Which Orchestra BioMed insiders have been buying company stock? The following insiders have purchased OBIO shares in the last 24 months: Andrew Lawrence Taylor ($4,830.00), David P Hochman ($77,015.00), and William Reed Little ($28,000.00). How much insider buying is happening at Orchestra BioMed? Insiders have purchased a total of 20,000 OBIO shares in the last 24 months for a total of $109,845.00 bought. Which Orchestra BioMed insiders have been selling company stock? The following insiders have sold OBIO shares in the last 24 months: Darren Sherman ($117,518.97), and Eric S Fain ($21,054.00). How much insider selling is happening at Orchestra BioMed? Insiders have sold a total of 24,260 Orchestra BioMed shares in the last 24 months for a total of $138,572.97 sold. Orchestra BioMed Key ExecutivesMr. David P. Hochman (Age 49)Founder, Chairman of the Board of Directors & CEO Compensation: $942k2 recent tradesMr. Darren R. Sherman (Age 53)Founder, President, COO & Director Compensation: $787kMr. Andrew Lawrence Taylor M.B.A. (Age 53)Chief Financial Officer Compensation: $500.02k1 recent tradesMr. William Reed Little (Age 53)Executive Vice President of Corporate Development & Strategy Dr. Yuval Hay Mika D.Sc (Age 65)Ph.D., GM & CTO of Bioelectronic Therapies Dr. George Papandreou Ph.D. (Age 59)GM & Senior VP of Focal Therapies Dr. Hans-Peter Stoll M.D.Ph.D., Chief Clinical OfficerDr. Avraham Matityahu Fischer M.D. (Age 68)Senior Vice President of Medical Affairs & Innovation Mr. Bob LaughnerSenior Vice President of Regulatory & QualityMr. Juan LorenzoSenior Vice President of Product Development More Insider Trading Tools from MarketBeat Related Companies NPCE Insider Buying DCTH Insider Buying SMLR Insider Buying TCMD Insider Buying CLPT Insider Buying CVRX Insider Buying LUNG Insider Buying ZIMV Insider Buying SMTI Insider Buying STIM Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:OBIO) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OBIO Stock Free OBIO Stock Alerts